HLA-B27 - ANKYLOSING SPONDYLITIS - ANVISA Registration 81148560047

Access comprehensive regulatory information for HLA-B27 - ANKYLOSING SPONDYLITIS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81148560047 and manufactured by EUROIMMUN AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including DNA-TECHNOLOGY, RESEARCH & PRODUCTION, MOBIUS LIFE SCIENCE INDÚSTRIA E COMERCIO DE PRODUTOS PARA LABORATÓRIOS LTDA, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
2 Competitors
81148560047
Registration Details
ANVISA Registration Number: 81148560047
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

81148560047

25351579199201602

93741726000166

Company Information

EUROIMMUN AG
Germany
PT: ALEMANHA

Dates and Status

Mar 27, 2017

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "HLA-B27 - ANKYLOSING SPONDYLITIS"